Citation Impact
Citing Papers
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
Macrophages Promote Axon Regeneration with Concurrent Neurotoxicity
2009
Infective Endocarditis
2005 Standout
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
2016 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study
2003
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Treatment of multiple sclerosis with Copolymer-1 (Copaxone®): implicating mechanisms of Th1 to Th2/Th3 immune-deviation
1998
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
The Peripheral Anionic Site of Acetylcholinesterase: Structure, Functions and Potential Role in Rational Drug Design
2005
The spectrum of neuromyelitis optica
2007 Standout
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
The role of tissue factor in the antiphospholipid syndrome
2001
Class Switch Recombination and Somatic Hypermutation in Early Mouse B Cells Are Mediated by B Cell and Toll-like Receptors
2007 StandoutNobel
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Glutamate uptake
2001 Standout
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development
2014
Stem Cell Therapies in Clinical Trials: Progress and Challenges
2015 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity
2012 StandoutNobel
Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus
2002
T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls
2001
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Repertoire of microglial and macrophage responses after spinal cord injury
2011 Standout
Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis
1998
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Primary open-angle glaucoma
2004 Standout
Multiple sclerosis
2008 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis
1998
Immunopathology of multiple sclerosis
2015 Standout
Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord
2009 Standout
Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis
2002
CD4 T‐cell epitopes of human α B‐crystallin
2004
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Novel B cell population producing functional IgG in the absence of membrane IgM expression
2002
Recognition of Conserved Amino Acid Motifs of Common Viruses and Its Role in Autoimmunity
2005 StandoutNobel
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
The Obese Strain of Chickens: An Animal Model with Spontaneous Autoimmune Thyroiditis
1989
The central nervous sytem-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS)
2000
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
2002 Standout
Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus
2003
REVIEW OF TREATMENT TRIALS IN HUMANSPINAL CORD INJURY
2006
Functional Specialization of Interleukin-17 Family Members
2011 Standout
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Multiple Sclerosis
2000 Standout
Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein
1999
In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis
2003
Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis
2000
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Spinal Cord Injury: Time to Move?
2007
Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens
2010
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Recurrent miscarriage
2006 Standout
Antigen Presentation in the CNS by Myeloid Dendritic Cells Drives Progression of Relapsing Experimental Autoimmune Encephalomyelitis
2007
Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury
2007
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Cellular Treatments for Spinal Cord Injury: The Time is Right for Clinical Trials
2011
Antiphospholipid antibodies and pregnancy
2003
Autoimmunity and Pregnancy
2006
T‐ and B‐cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis
2001
Multiple sclerosis
2002 Standout
T Cell-Specific Loss of Pten Leads to Defects in Central and Peripheral Tolerance
2001 StandoutNobel
β2-Microglobulin-Deficient Background Ameliorates Lethal Phenotype of the TGF-β1 Null Mouse
1999
The Complex Role of Estrogens in Inflammation
2007 Standout
Mechanisms of action of glatiramer acetate in multiple sclerosis
2001
Harnessing monocyte‐derived macrophages to control central nervous system pathologies: no longer ‘if’ but ‘how’
2012
Pathogenesis of Group A Streptococcal Infections
2000 Standout
Steric and Dynamic Parameters Influencing In Situ Cycloadditions to Form Triazole Inhibitors with Crystalline Acetylcholinesterase
2016 StandoutNobel
Immunization with a Peptide Surrogate for Double-stranded DNA (dsDNA) Induces Autoantibody Production and Renal Immunoglobulin Deposition
1998
The Regulation of Thyroid Function in Pregnancy: Pathways of Endocrine Adaptation from Physiology to Pathology
1997
The Biology of NKT Cells
2006 Standout
Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus
2003
Can the immune system be harnessed to repair the CNS?
2008
Antagonizing the α4β1 Integrin, but Not α4β7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis
2013
Primary Biliary Cirrhosis
2011 Standout
Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis
2001
Thrombosis and Antiphospholipid Syndrome: a Preliminary Assessment of Three Antithrombotic Treatments
1994
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
Descending Pathways in Motor Control
2008 Standout
Transplantation of Autologous Olfactory Ensheathing Cells in Complete Human Spinal Cord Injury
2013
Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
1995
Critical Roles of Pten in B Cell Homeostasis and Immunoglobulin Class Switch Recombination
2003 StandoutNobel
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Periodontal Disease, Atherosclerosis, Adverse Pregnancy Outcomes, and Head-and-Neck Cancer
2014
CD28 disruption exacerbates inflammation in Tgf-β1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-β1
2004 StandoutNobel
Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome
1996
Autoantibodies to the Glutamate Receptor Kill Neurons via Activation of the Receptor Ion Channel
1999
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Increased CD8+ Cytotoxic T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
2004
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse.
1999
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma
2001
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability
1998
The Human T Cell Response to Myelin Oligodendrocyte Glycoprotein: A Multiple Sclerosis Family-Based Study
2002
High Immunogenicity of Intracellular Myelin Oligodendrocyte Glycoprotein Epitopes
2002
Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse
1996
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: Possible therapy for optic neuropathies
2000
Works of Ronit Bakimer being referenced
Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3.
1993
Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis
1991
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions
1997
Clinically insignificant (natural) autoantibodies against acetyl cholinesterase in the sera of patients with a variety of neurologic, muscular and autoimmune diseases
1997
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).
1992
Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results
2005
The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: Effect of copolymer 1 on MOG-induced disease
1996
Detection of Antimitochondrial Antibodies: Characterization by Enzyme Immunoassay and Immunoblotting
1989
Detection of Anti-Phospholipid and Anti-DNA Antibodies and their Idiotypes in Newborns of Mothers with Anti-Phospholipid Syndrome and SLE
1993
WHAT REALLY HAPPENS TO FECUNDITY IN AUTOIMMUNE DISEASES?
1994
The genetic regulation of the induction of experimental SLE.
1990
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype.
1988